 |
Although the life science industry has been exploring the use of digital technologies to simplify the informed consent process, COVID-19 proved to be an inflection point for the industry to implement digital technologies in earnest. The eClinical technology industry has benefitted by implementing design techniques and user-centric approaches gleaned from consumer-oriented industries to overcome historic objections. Yet, the industry remains divided on the value of creating a digital consent solution—the informed consent process is either too simple to invest money in, or too complicated for an effective technology solution. In this article, YPrime experts discuss:
|
